The forced swimming test as a model for core and component behavioral effects of antidepressant drugs

Behavioural Pharmacology

Volumn 8, Issue 6-7, 1997, Pages 523-532

  Lucki, I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Animal models; Antidepressants; Behavior; Depression; Serotonin reuptake inhibitors

Indexed keywords

4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DIAZEPAM; DIHYDROTACHYSTEROL; DULOXETINE; FLUOXETINE; GEPIRONE; IPRINDOLE; MAPROTILINE; MIANSERIN; MILNACIPRAN; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VANOXERINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; DEPRESSION; FORCED SWIMMING TEST; NONHUMAN; RAT; REVIEW;

EID: 0030819696     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199711000-00010     Document Type: Review

References (58)

1. Artigas F (1995) Selective serotonin/noradrenaline reuptake inhibitors (SNRIs) pharmacology and therapeutic potential in the treatment of depressive disorders. CNS Drugs, 4, 79-89.
2. Aston-Jones G, Shipley MT, Chouvet G, Ennis M, van Bockstaele V, Pieribone V, Shiekhatter R, Akaoka H, Drolet G, Astier P et al. (1991) Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Progress in Brain Research, 88, 47-76.
3. Barnett A and Taber RI (1971) Antidepressant agents. In: Screening Methods in Pharmacology (Eds RA. Turner and P. Hebborn), pp. 209-226. Academic Press, New York.
4. Bel N and Artigas F (1996) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. Journal of Pharmacology and Experimental Therapeutics, 278, 1064-1072.
5. Bizot JC, Thiébot MH, Le Bihan C, Soubié P and Simon P (1988) Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. Journal of Pharmacology and Experimental Therapeutics, 246, 1144-1151.
6. Blier P and de Montigny C (1994) Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences, 15, 220-226.
7. Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neuroscience and Biobehavioral Reviews, 19, 377-395.
8. Borsini F and Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology, 94, 147-160.
9. Cairncross KD, Cox B, Forster C and Wren AF (1978) A new model for the detection of antidepressant drugs: olfactory bulbectomy in the rat compared with existing models. Journal of Pharmacological Methods, 1, 131-143.
10. Caldecott-Hazard S and Schneider LS (1992) Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies. Synapse, 10, 141-168.
11. Cervo L, Grignaschi G, Rossi C and Samanin R (1991) Rose of serotonergic neurons in the effect of sertraline in rats in the forced swimming test. European Journal of Pharmacology, 196, 217-222.
12. Chen NH and Reith MEA (1994) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study of monoamine interrelationships. Journal of Neurochemistry, 63, 1701-1713.
13. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, Heninger GR and Charney DS (1991) Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. Psychopharmacology Bulletin, 27, 321-330.
14. Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ and Charney DS (1993) Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacology Bulletin, 29, 389-396.
15. Detke MJ and Lucki I (1995) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behavioural Brain Research, 73, 43-46.
16. Detke MJ, Kirby L and Lucki I (1995a) Serotonergic mechanisms involved in the effects of fluoxetine in the rat forced swimming test (FST). Society for Neuroscience Abstracts, 21, 976.
17. Detke MJ, Rickels M and Lucki I (1995b) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121, 66-72.
18. Detke MJ, Johnson J and Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology, 5, 107-112.
19. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology, 121, 1-26.
20. 2-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacology, Biochemistry and Behavior, 49, 107-113.
21. Hansen HH, Sanchez C and Meier E (1997) Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? Journal of Pharmacology and Experimental Therapeutics, in press.
22. Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J, Kong N, Smith JE, Davies HML and Dworkin SI (1997) Potential antidepressant effects of novel tropane compounds selective for serotonin or dopamine transporters. Journal of Pharmacology and Experimental Therapeutics, 282, 727-733.
23. Holsboer F (1995) Neuroendocrinology of mood disorders. In: Psychopharmacology The Fourth Generation of Progress (Eds FE Bloom and DJ Kupfer), pp. 957-970. Raven Press, New York.
24. Joly D and Sanger DJ (1986) The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats. Pharmacology, Biochemistry and Behavior, 24, 199-204.
25. Katz MM and Maas JW (1994) Psychopharmacology and the etiology of psychopathologic states: are we looking in the right way? Neuropsychopharmacology, 10, 139-144.
26. Katz MM, Maas JW, Frazer A, Koslow SH, Bowden CL, Berman N, Swann AC and Stokes PE (1994) Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology, 11, 89-100.
27. Katz MM, Koslow SH and Frazer A (1997) Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depression and Anxiety, 4, 257-267.
28. Lazarus RS (1993) Coping theory and research: past, present and future. Psychosomatic Medicine, 55, 234-247.
29. Leshner AI, Remler H, Biegon A and Samuel D (1979) Effects of desmethylimipramine (DMI) on learned helplessness. Psychopharmacology, 66, 207-213.
30. Lucki I, Singh A and Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neuroscience and Biobehavioral Reviews, 18, 85-95.
31. McNaughton ME, Patterson TL, Irwin MR and Grant I (1992) The relationship of life adversity, social support, and coping to hospitalization with major depression. Journal of Nervous and Mental Disorders, 180, 491-497.
32. Maier SF and Jackson RL (1979) Learned helplessness: all of us were right (and wrong): inescapable shock has multiple effects. In: The Psychology of Learning and Motivation (Ed G Bower), vol. 13, pp. 155-218. Academic Press, New York.
33. Maj J, Rogoz Z and Skuza G (1992) The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Polish Journal of Pharmacology and Pharmacy, 44, 217-226.
34. 1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. Journal of Pharmacology and Experimental Therapeutics, 250, 60-71.
35. Martin P, Soubrié P and Puech AJ (1990) Reversal of helplessness behavior by serotonin uptake blockers in rats. Psychopharmacology, 101, 403-407.
36. Matthews WD and Smith CD (1980) Pharmacological profile of a model for central serotonin receptor activation. Life Sciences, 26, 1397-1403.
37. Möller H-J and Volz H-P (1996) Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs, 52, 625-638.
38. Muscat R, Papp M and Willner P (1992) Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology, 109, 433-438.
39. Nelson JC, Mazure CM, Bowers MB and Jatlow PI (1991) A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Archives of General Psychiatry, 48, 303-307.
40. Overstreet DH (1993) The Flinders sensitive line rats: a genetic animal model of depression. Neuroscience and Biobehavioral Reviews, 17, 51-68.
41. Paul IA, Duncan GE, Kuhn C, Mueller RA, Hong J and Breese GR (1990) Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake. Journal of Pharmacology and Experimental Therapeutics, 252, 997-1005.
42. Porsolt RD and Lenegre A (1992) Behavioral models of depression. In: Experimental Approaches to Anxiety and Depression (Eds JM Elliot, DJ Heal and CA Marsden), pp. 73-85. John Wiley and Sons, New York.
43. Porsolt RD, Le Pichon M and Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
44. Porsolt RD, Anton G, Deniel M and Jalfre M (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology, 47, 379-391.
45. Porsolt RD, Bertin A, Blavet N, Deniel M and Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. European Journal of Pharmacology, 57, 201-210.
46. Ravindran AV, Griffiths J, Waddell C and Anisman H (1995) Stressful life events and coping styles in relation to dysthymia and major depressive disorder: variations associated with alleviation of symptoms following pharmacotherapy. Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 637-653.
47. Reneric JP and Lucki I (1997) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology, in press.
48. Richelson E (1994) Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clinic Proceedings, 69, 1069-1081.
49. Seiden LS and O'Donnell JM (1985) Effects of antidepressant drugs on DRL behavior. In: Behavioral Pharmacology: The Current Status (Eds LS Seiden and RL Balster), pp. 323-338. Alan R. Liss, New York.
50. Seligman MEP, Rossellini R and Kozak M (1975) Learned helplessness in the rat: reversibility, time course and immunization. Journal of Comparative and Physiological Psychology, 88, 542-547.
51. Seth R, Jennings AL, Bindman J, Phillips J and Bergmann K (1992) Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. British Journal of Psychiatry, 161, 562-565.
52. Sherman AD, Sacquitne JL and Petty F (1982) Specificity of the learned helplessness model of depression. Pharmacology, Biochemistry and Behavior, 16, 449-454.
53. Slater IH, Rathbun R and Kattau R (1979) Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice. Journal of Pharmacy and Pharmacology, 31, 108-110.
54. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology, 345, 137-143.
55. Vandermaelen CP and Aghajanian GK (1983) Electrophysiological and pharmacological characterization of serotonergic dorsal raphé neurons recorded extracellularly and intracellularly in rat brain slices. Brain Research, 289, 109-113.
56. Willner P (1990) Animal models of depression: an overview. Pharmacology and Therapeutics, 45, 425-455.
57. Willner P, Muscat R and Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews, 16, 525-534.
58. Wong DT, Bymaster FP and Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sciences, 57, 411-441.